After years of trying, researchers have finally shown that a targeted anti-inflammatory agent can guard against life-threatening plaque ruptures in heart attack survivors who remain at risk of further vascular events despite well-controlled lipid levels…
Fonte: Nature Reviews Drug Discovery | Published online 29 Sep 2017
Para acessar a publicação na íntegra clique aqui